Cresco Labs Inc.

Canadian Sec Stock Exchange CL.CN

Cresco Labs Inc. Capital Expenditure for the year ending December 31, 2023: USD -57.88 M

Cresco Labs Inc. Capital Expenditure is USD -57.88 M for the year ending December 31, 2023, a 32.80% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Cresco Labs Inc. Capital Expenditure for the year ending December 31, 2022 was USD -86.13 M, a 11.25% change year over year.
Cresco Labs Inc. Capital Expenditure for the year ending December 31, 2021 was USD -97.05 M, a -20.75% change year over year.
Cresco Labs Inc. Capital Expenditure for the year ending December 31, 2020 was USD -80.38 M, a 16.38% change year over year.
Cresco Labs Inc. Capital Expenditure for the year ending December 31, 2019 was USD -96.13 M, a -221.02% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Canadian Sec Stock Exchange: CL.CN

Cresco Labs Inc.

CEO	Mr. Charles Bachtell
IPO Date	Aug. 8, 1996
Location	United States
Headquarters	400 West Erie Street
Employees	2,760
Sector	Consumers Staples
Industries Tobacco Alcoholic Beverages Bread & Bakery Drugstores & Retail Pharmacies Frozen Foods Non-Alcoholic Beverages Snack Foods Soft Drinks & Sodas

Description

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand, as well as cannabis products under the Reserve brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections, fruit-forward gummies, hard sweets, and taffy under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. As of December 6, 2022, it owned and operated 55 dispensaries. The company was founded in 2013 and is headquartered in Chicago, Illinois.

Key trends

Past 5 years